HCID 10155472, compound → HCID 86584930, compound
Reaction equation
[CH3:1][O:2][C:3](=[O:20])[NH:4][C:5]1[S:6][C:7]2[C:13]([CH:14]([OH:17])[CH2:15][Br:16])=[CH:12][CH:11]=[C:10]([O:18][CH3:19])[C:8]=2[N:9]=1>C(Cl)(Cl)Cl.O=[Mn]=O>[CH3:1][O:2][C:3](=[O:20])[NH:4][C:5]1[S:6][C:7]2[C:13]([C:14](=[O:17])[CH2:15][Br:16])=[CH:12][CH:11]=[C:10]([O:18][CH3:19])[C:8]=2[N:9]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
1.6 g of rac-[7-(2-bromo-1-hydroxy-ethyl)-4-methoxy-benzothiazol-2-yl]-carbamic acid methyl ester (0.0044 Mol) were dissolved in CHCl3 (100 ml) and treated with 3.8 g of MnO2 (0.044 Mol) for 3 hrs. at 70° C. The hot reaction mixture was filtered and subsequently concentrated. The crude product was crystallized from Et2O to yield the title compound as a beige solid (73%); F.p.: 250-260° C. (dec.).
Workup
- customat 70° C
- filtrationThe hot reaction mixture was filtered
- concentrationsubsequently concentrated
- customThe crude product was crystallized from Et2O
Sources & evidence
- ORD record
- ord-6d24030bee7d43c5b5f96fa23a099b7a
- Source dataset
- uspto-grants-2004_12
- Patent number
- US06835732B2
Reaction notes
Loading…